LIFEPHARMA is very active in the marketing of medicinal products for the orthopaedic area, particularly against osteoporosis, inflammation and pain.
Osteoporosis is a disease that strikes over 4.5 million people in Italy, particularly the elderly. It is a silent disease with few symptoms and may have serious, disabling effects in the short term. All patients need treatment with calcium and vitamin D: the recommended levels are very often not reached with the diet and exposure to sunlight alone. Through its research and development activities, the Italfarmaco Group has, over the years, produced a wide range of medicinal products with formulations and doses required for personalized treatments optimized in terms of efficacy, adherence to treatment and safety.
- NatecalD3, (calcium carbonate and vitamin D3) in chewable and orally disintegrating tablets containing 600 mg of calcium and 400 IU of vitamin D, provides the necessary intake, due to its known excellent palatability, to patients with insufficient calcium in their diet.
- Natemille, in 600 mg orally disintegrating tablets and 1,000 IU of vitamin D3, provides the daily vitamin D intake recommended by the main guidelines and a sufficient quantity of calcium for patients that already consume a certain amount of calcium in their diet.
Pain and inflammation
Patients suffering from inflammatory processes, nearly always accompanied by acute and chronic pain, need rapid, well-tolerated solutions for their symptoms.
In this therapeutic area, Lifepharma offers a molecule of proven efficacy, that is Ketoprofene, available in several technologically advanced formulations capable of meeting the various therapeutic needs (acute and chronic treatments).
Flexen (ketoprofen 50 mg capsules; 200 mg prolonged-release capsules; 50g tube containing 5% gel; 100 mg suppositories; 100 mg solution for i.v. injection; 100 mg solution for i.m. injection) is a full range of formulations for targeting acute and chronic inflammatory and painful disorders of the musculoskeletal system.